17-81144773-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001080395.3(AATK):c.56-10272A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.488 in 152,144 control chromosomes in the GnomAD database, including 18,471 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.49 ( 18471 hom., cov: 34)
Consequence
AATK
NM_001080395.3 intron
NM_001080395.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.53
Publications
14 publications found
Genes affected
AATK (HGNC:21): (apoptosis associated tyrosine kinase) The protein encoded by this gene contains a tyrosine kinase domain at the N-terminus and a proline-rich domain at the C-terminus. This gene is induced during apoptosis, and expression of this gene may be a necessary pre-requisite for the induction of growth arrest and/or apoptosis of myeloid precursor cells. This gene has been shown to produce neuronal differentiation in a neuroblastoma cell line. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.55 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AATK | ENST00000326724.9 | c.56-10272A>G | intron_variant | Intron 1 of 13 | 5 | NM_001080395.3 | ENSP00000324196.4 | |||
| AATK | ENST00000374792.6 | n.56-10272A>G | intron_variant | Intron 1 of 15 | 2 | ENSP00000363924.2 | ||||
| AATK | ENST00000572798.1 | n.274-10272A>G | intron_variant | Intron 2 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.488 AC: 74224AN: 152026Hom.: 18454 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
74224
AN:
152026
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.488 AC: 74279AN: 152144Hom.: 18471 Cov.: 34 AF XY: 0.482 AC XY: 35836AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
74279
AN:
152144
Hom.:
Cov.:
34
AF XY:
AC XY:
35836
AN XY:
74374
show subpopulations
African (AFR)
AF:
AC:
23077
AN:
41488
American (AMR)
AF:
AC:
7224
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
1425
AN:
3470
East Asian (EAS)
AF:
AC:
1482
AN:
5170
South Asian (SAS)
AF:
AC:
1577
AN:
4828
European-Finnish (FIN)
AF:
AC:
4868
AN:
10584
Middle Eastern (MID)
AF:
AC:
136
AN:
294
European-Non Finnish (NFE)
AF:
AC:
32912
AN:
67988
Other (OTH)
AF:
AC:
989
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2013
4025
6038
8050
10063
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
666
1332
1998
2664
3330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1002
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.